Blueprint Medicines (BPMC) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Blueprint Medicines Corporation  (NASDAQ: BPMC)
 

Blueprint Medicines Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BPMC Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 55.45 % 4.83 % 3.99 % 4.2 %
Q / Q Revenue Growth (Q1 MRQ) 2.08 % -8.49 % -5.34 % -3.92 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 95.16 % 7.88 % 5.43 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 10.47 % 0.94 % 0.76 % 1.07 %
Revenue 5 Year Average Growth 44.69 % 14.14 % 10.99 % 7.73 %


BPMC's Growth Comparisons in I. Quarter 2025




Strong but slowing Revenue rise by Blueprint Medicines of 55.45% year on year , in the first quarter 2025 to 149 millions, was higher than the 4.83% growth in the Major Pharmaceutical Preparations industry, and 3.99% growth in the Healthcare sector. Comparing the first quarter sales growth, both Major Pharmaceutical Preparations industry and Blueprint Medicines Corporation outperformed 4.2% overall market increase.

Comparing the company's Revenue to the fourth quarter results, sales were higher by 2.08% . On the yearly basis, average annual sales growth for Blueprint Medicines is 44.69%, while S & P 500's including only Businesses with the first quarter 2025 earnings, average annual sales growth is 7.73% over the past five years.

BPMC Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Product
61.48 %
-
Product United States
55.7 %
-
Product Rest of World
112.66 %
-
Valuation Allowances and Reserves Product Revenue
28.07 %
-
Single Reportable Segment
55.45 %
-
Total
55.45 %
-


Growth Rates of BPMC's Income in the first quarter 2025


BPMC Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - 172.13 % 98.32 % 2.39 %
Sequential Operating Income Change (Q1 MRQ) - 55.43 % 29.36 % 12.67 %
Y / Y Operating Income Growth (Q1 TTM) - 126.07 % 77.41 % 6.79 %
Sequential Operating Income Growth (Q1 TTM) - 22.55 % 17.31 % 0.65 %
Operating Income 5 Year Avg. Change - 0.11 % -0.96 % 9 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) -99.44 % 898.07 % 254.08 % 14.03 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - - 3992.22 % 0.54 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 212.02 % 146.7 % 13 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - 34.82 % 14.55 % 2.54 %
Income from Cont. Ops. 5 Year Avg. Change - -18.69 % -17.93 % 8.34 %

BPMC Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) -99.44 % 887.74 % 257.84 % 13.51 %
Q / Q Net Income Growth (Q1 MRQ) - 14.78 % 19.03 % -0.08 %
Y / Y Net Income Change (Q1 TTM) - 62.88 % 57.78 % 11.01 %
Sequential Net Income Change (Q1 TTM) - 32.51 % 23.6 % 2.45 %
Net Income 5 Year Avg. Growth - 14.51 % 6.2 % 9.47 %

BPMC's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) -99.31 % 665.83 % 254.08 % 14.03 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - - 3992.22 % 0.54 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - - - -23.98 %
EPS from Cont. Ops. 5 Year Avg. Growth - -29.47 % -17.93 % 8.34 %



BPMC EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) -99.29 % 657.91 % 257.84 % 8.34 %
Q / Q EPS Net Growth (Q1 MRQ) - 2.54 % 19.03 % -0.08 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 0.14 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - - - -23.99 %
EPS Net 5 Year Avg. Change - 14.51 % 6.2 % 9.47 %



As Blueprint Medicines's income per share faded by -99.29% year on year in the first quarter, Major Pharmaceutical Preparations industry grew by 657.91%, Blueprint Medicines's first quarter performance was trailing Major Pharmaceutical Preparations, and underperformed the 257.84% EPS surge in the Healthcare sector. Although both Major Pharmaceutical Preparations industry and Healthcare sector posted higher gains than 13.51% overall market increase, Blueprint Medicines was trailing overall market in the first quarter.

Comparing company's EPS to the fourth quarter results, income per share were higher by 2.08% . On the yearly basis, average annual income per share growth for Blueprint Medicines is 44.69%, while S & P 500's including only the businesses with the first quarter 2025 Results, average annual income per share growth is 9.47% over the past five years.

BPMC Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - -12.95 % -2.89 % -92.81 %
Sequential Free Cash Flow Change (Q1 MRQ) - -66.41 % -70.2 % -98.71 %
Y / Y Free Cash Flow Change (Q1 TTM) - 33.93 % 27.33 % 7.78 %
Sequential Free Cash Flow Change (Q1 TTM) - 12.59 % 7.43 % -2.25 %
Free Cash Flow 5 Year Avg. Change - 9.45 % 6.34 % 10.76 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) -53.52 % 278.38 % - -
Sequential Net Cash Flow Change (Q1 MRQ) 40.33 % 131.68 % - -
Y / Y Net Cash Flow Change (Q1 TTM) - - -80.31 % -
Sequential Net Cash Flow Change (Q1 TTM) - - -59.61 % -
Net Cash Flow 5 Year Avg. Change -6.48 % -8.21 % -1.7 % -32.35 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 65.85 % 16.98 % 6.89 % 18.29 %
Sequential Capital Expenditures Change (Q1 MRQ) 96.46 % -19.18 % -19.49 % -17.95 %
Y / Y Capital Expenditures Change (Q1 TTM) -63.26 % 14.59 % 7.83 % 39.53 %
Sequential Capital Expenditures Change (Q1 TTM) 15.7 % 10.45 % 4.13 % 5.69 %
Capital Expenditures 5 Year Avg. Change -19.87 % 10.81 % 9 % 10.74 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.